Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 125 of 441 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/12/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 10/17/24
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 12/03/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 10/11/21
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 01/01/16
End: 02/28/23
Due: 02/28/24
Phase: N/A
Priority: Normal
Start: 08/12/24
End: 08/12/26
Due: 08/12/27
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 05/08/13
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 11/08/17
End: 11/08/23
Due: 11/08/24
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
Phase: N/A
Priority: Normal
Start: 05/06/22
End: 05/31/32
Due: 05/31/33
Phase: N/A
Priority: Normal
Start: 08/01/24
End: 02/01/27
Due: 02/01/28
Phase: N/A
Priority: Normal
Start: 06/01/01
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 03/02/21
End: 12/06/21
Due: 12/06/22
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/15/21
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 07/07/20
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 08/30/24
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 12/31/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 03/10/20
End: 04/05/22
Due: 04/05/23
Phase: N/A
Priority: Normal
Start: 04/10/18
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 05/02/18
End: 01/01/21
Due: 01/01/22
Phase: N/A
Priority: Normal
Start: 07/30/20
End: 07/30/21
Due: 07/30/22
Phase: N/A
Priority: Normal
Start: 04/01/16
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 08/28/24
End: 12/31/26
Due: 12/31/27